Skip to main content
. 2020 Jun 17:1–17. doi: 10.1080/03602532.2020.1770782

Table 2.

The different monoclonal antibodies (mAbs) in various stages of research and development to neutralize the coronavirus.

Antibody name Source Organization Study type Target Reference
REGN3048/REGN3051 Humanized mouse Regeneron Mouse/NHP efficacy RBD (Pascal et al. 2015)
G2, G4, D12, F11, S/S1 immunized mouse NIH NIAID NHP efficacy S1, S2, RBD (Wang et al. 2015)
2E6, 4C2 RBD immunized mice Chinese Academy of Sciences Mouse efficacy RBD (Li et al. 2015)
LCA60 Human survivor HUMABS BioMed Mouse/NHP efficacy RBD (Corti et al. 2015)
3B11 (AV-3) Human antibody library Dana-Farber Cancer Institute and AbViro LLC NHP efficacy RBD (Tang et al. 2014)
m336, m337, m338 Human antibody library NIH National Cancer Institute In vitro RBD (Xia et al. 2014)